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Summary 
Prointerleukin-l[3 (pro-IL-l[3) is the only known physiologic substrate of the interleukin-l[3 
(IL-l[3)-converting enzyme (ICE),  the founding member of the ICE/ced-3  cell death gene 
family. Since secreted mature IL-113 has been detected after apoptosis, we investigated whether 
this cytokine, when produced endogenously, plays a role in ceil death. We found that hypoxia- 
induced apoptosis can be inhibited by either the IL-1 receptor antagonist (IL-11ka) or by neu- 
tralizing antibodies to IL-1 or to its type 1 receptor. IL-1Ra also inhibits apoptosis induced by 
trophic factor deprivation in primary neurons, as well as by tumor necrosis factor ix in fibro- 
blasts.  In addition,  during the  G1/S phase  arrest,  mature IL-l[3 induces apoptosis through a 
pathway independent of CrmA-sensitive gene activity. We also demonstrate that Ice, when ex- 
pressed in COS  cells,  requires the coexpression ofpro-IL-l~  for the induction of apoptosis, 
which is inhibited by IL-1Ra. Interestingly, we found that mature IL-113 has antiapoptotic ac- 
tivity when added exogenously before the onset of hypoxia, which we found is caused in part 
by its ability to downregulate the IL-1 receptor. Our findings demonstrate that pro-IL-l[3 is a 
substrate of ICE relevant to cell death, and depending on the temporal cellular commitment to 
apoptosis, mature IL-1 [3 may function as a positive or negative mediator of cell death. 
A 
Poptosis, a process by which organisms eliminate un- 
wanted  cells,  is executed through the  activation of a 
tightly regulated program  (1).  A  genetic pathway of pro- 
grammed  cell  death  was  first  identified in  the  nematode 
Caenorhabditis  elegans.  In  this  worm,  the  products  of the 
ted-3 and ced-4 genes carry out the program of cellular sui- 
cide (2). IL-l[3-converting enzyme (ICE) 1, a cysteine pro- 
tease  responsible  for the  activation of pro-interleukin-l[3 
(pro-IL-t[3), is a mammalian homologue of CED-3 (3-5). 
Previous work has demonstrated that Ice overexpression in- 
duces programmed cell death, and that mature IL-113 is re- 
leased  during  apoptosis  mediated via  a  variety of stimuli 
(LPS,  TNF-IX,  and  Shigella  flexneri  infection)  (5-8).  The 
cowpox virus gene product CrmA, a member of the serpin 
family and an inhibitor of ICE,  prevents apoptosis  (5,  7, 
9-13).  Furthermore, the inhibition of apoptosis  mediated 
by  CrmA  correlates with  its  inhibition  of mature  IL-l[3 
1Abbreviations used in this paper: DRG, dorsal root ganglia; HU, hydroxy- 
urea; ICE, IL-l~:onverting enzyme; IL-Ra, IL-1 receptor agonist; 
NGF, nerve growth factor;  pro-IL-I  [3, prointerleukin-H3. 
production  (7).  Recent  reports  indicate  that  TNF-~- 
induced apoptosis is mediated through a CrmA-inhibitable 
pathway,  suggesting  the  involvement  of the  ICE  family 
(7, 14). The detection of mature IL-113 release during apop- 
tosis  strongly suggests  that  ICE  is  activated in  cell  death 
since in vivo, ICE is the major (if not the only) protease re- 
sponsible for processing pro-IL-l[3 (15,  16). 
While the critical role of the ICE family in cell death is 
well accepted, the function of mature IL-l[3 in apoptosis is 
controversial. Exogenous IL-113 has been shown to induce 
apoptosis in some systems  (17-19) and to prevent it in oth- 
ers  (20,  21).  In  this  study,  we  establish  a  dual functional 
role  for  mature  IL-113 in  ICE-mediated  apoptosis.  We 
found that when  produced  endogenously (i.e.,  after ICE 
activation), IL-113 mediates cell death, but when provided 
exogenously,  IL-113 can  either  stimulate  or  inhibit  cell 
death. We demonstrate that if IL-l[3 binds to its  receptor 
before exposure to  an apoptotic stimulus,  it inhibits  pro- 
grammed cell death (by downregulating the IL-1 receptor); 
in contrast, ifIL-l[3 binds after ICE is activated, it enhances 
cell death. In addition, we demonstrate that Ice requires the 
coexpression ofpro-IL- 1r  to induce apoptosis in COS cells. 
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to  its receptor,  indicating that  after  ICE  activation,  COS 
cells required IL-l{3 signal transduction for the completion 
of the  suicide program.  Our  results  demonstrate  that  en- 
dogenously produced mature  IL-lf3 plays an  integral role 
in ICE-mediated apoptosis. 
Materials and Methods 
Hypoxia-inducedApoptosis Assay.  HeLa  and  HeLa/CrmA cells 
were  seeded in  35-mm  dishes at a  density of 6  ￿  104/dish  in 
DMEM/10% FCS and grown overnight. The medium was then 
changed, and factors were added: IL-1Ra (R & D  Systems, Min- 
neapolis, MN), IL-1 antibody (Calbiochem-Novabiochem Corp., 
San Diego, CA), or IL-1 type 1 receptor antibody (R & D  Sys- 
tems). Dishes were placed in an anaerobic chamber with a BBL 
GasPack Plus  (Becton Dickinson, Cockeysville, MD), which re- 
duces  the  oxygen concentration to  <100  ppm within  90  rain. 
After 16 h,  cells were removed from the chamber, immediately 
trypsinized, and scored for viability by trypan blue exclusion. 
Inhibition of S2sI-IL-l~ Binding by IL-IRa.  HeLa cells (106) were 
seeded in  10-cm dishes,  and after an  overnight incubation, IL- 
1Ra was added for 2 h at 37~  After the addition of  BSA (1 mg/ 
n~l) to the medium, the cells were incubated at 4~  for 15 rain, 
and then ~2sI-IL-l[~ (100  ng/ml) was added at 4~  for 1 h.  For 
detection of 12sI-IL-113 binding, cells were treated with 50 mM 
glycine-HG1, pH 2.6, for 1 rain and quantitated by 3, counting. 
Neutvnal Trophic Factor  Deprivation Assay.  Postnatal  day 1 mouse 
dorsal  root  ganglia  (DRG)  neurons  were  isolated,  dissociated 
with trypsin for 1 h at 37~  and plated in an eight-chamber slide 
coated with poly-L-lysine/laminin (Sigma Immunochemicals, St. 
Louis, MO). Wells were seeded at a density of N1,000 neurons/ 
well (eight wells per mouse).  Neurons were cultured in Ham's 
F-12 media supplemented with 20% FCS (Biowhittaker, Walkes- 
ville,  MD),  nerve  growth  factor  ([NGF]  200  ng/ml;  Sigma), 
brain-derived  neurotrophic  factor  (100  ng/ml;  Preprotech, 
Rocky Hill, NJ), glutamine (2 raM), and penicillin/streptomycin. 
The medium was replaced daily with either trophic factor con- 
taining medium  (TF(+)  =  20% FCS and NGF [200 ng/ml]) or 
trophic factor-deficient medium (TF(-) =  serum and NGF-free 
medium in  the presence of a saturating concentration of mouse 
NGF mAb (100 ng/ml; Boehringer Mannheim, Indianapolis, IN), 
and IL-11Ka (100  ng/ml, unless  otherwise indicated in the text). 
Healthy neurons were counted using a phase contrast microscope 
24 and 48 h after the initial media change. 
Growth Arrest/Cytokine-induced Apoptosis Assay.  L929,  HeLa, 
and HeLa/CrmA cells were seeded (2  X  104  cells/well) in 24- 
well plates and grown overnight in DMEM with 10% FCS. After 
12 h, the cells were washed three times with serum-flee DMEM, 
and hydroxyurea ([HU] 2.5 raM; Sigma) was added to HeLa and 
HeLa/CrmA cells (22). After 5 h, IL-1Ra (40 ng/ml) was added 
to the appropriate wells, and 1 h later, either TNF-a or mature 
[L-l[3 (generous gift from Dr.  Lee Gehrke, Massachusetts  Insti- 
tute of Technology, Cambridge, MA) was added. 24 h later, IL- 
llKa was again added to the appropriate wells, and cell death was 
evaluated by trypan blue exclusion 60 h after the initial addition 
of HU.  Each condition was  tested independently three times in 
duplicate, and 200 cells were counted per well. For nuclear mor- 
phology  determination,  cells  were  grown  on  two-well  slides, 
fixed in 4% paraformaldehyde, and incubated with Hoechst dye 
No. 33258  (10 ~g/ml; Sigma). 
COS Cell Transfections.  COS  cells were plated (2  ￿  104) in 
six-well plates in DMEM with  10%  FCS. After 12 h,  the wells 
were  washed with serum-free and  antibiotic-free medium,  and 
were transfected using lipofectamine with either Ice--lacZ, ~ actin- 
IacZ (1 ~g), or pro-IL- 1~ (0.5 ~g) for 3 h. The medium was then 
replaced with DMEM/10%  FCS.  IL-1P,  a  (40  ng/ml)  was  then 
added to the appropriate wells, and after 1 h, IL-113 (100 ng/ml) 
was added. X-gal staining was performed 36 h after the transfec- 
tion, and the percentage of round blue (dead) cells was scored (5). 
Immunostaining.  COS cells (1.5  ￿  104/chamber) were plated 
in a poly-L-lysine-coated  two-chamber slide and transfected after 
12  h,  as described above.  Cells were fixed after 36  h  with 4% 
paraformaldehyde (15  min),  blocked  with  1%  heat-inactivated 
goat serum/2% BSA in PBS  (2 h), and incubated with a rabbit 
polyclonal antibody against IL-1  (1:300;  Calbiochem-Novabio- 
chem)  plus  a  hybridoma supematant  containing a  mouse  n~lb 
raised against human ICE (12 h at 4~  Cells were then washed 
3X  with  PBS  and  incubated  with  a  goat  anti-mouse  FITC- 
labeled antibody plus a goat anti-rabbit R.ITC-labeled antibody 
(1:200;  Cappel Laboratories, Durham, NC) and Hoechst dye No. 
33258 (10 mg/ml) for 45 min. Cells were rinsed three times with 
PBS, examined with an Axioplan microscope, and photographed 
with a 40￿  objective. 
IL-1 R~eptorDownregulation.  1L-1[3 (100  ng/ml)  was  added 
as the cells were placed into the hypoxia chamber (90 rain are re- 
quired to reach oxygen concentrations of 100 ppm). IL-1 recep- 
tor-binding assay: HeLa cells (10  e') were seeded in  10-cm dishes 
and grown overnight. Media was then  exchanged containing 1 
mg/ml of BSA and 100 ng/ml of 125t-IL-113 at 4~  for I h. After 
washing twice with cold medium, the cells were incubated with 
fresh warm medium at 37~  for 0,  30,  60,  and  120  rain.  Cells 
were then treated as described above with glycine, and the radio- 
activity was scored. 
Results 
Endogenously Produced Mature IL- 1~ Plays a Role in a CrmA- 
inhibitable Apoptosis Pathway Induced by Hypoxia.  Recently, 
BCL-2 and p53 have been implicated in hypoxia-mediated, 
apoptosis  (23-25).  To  investigate if the  ICE  family is  in- 
volved in  hypoxia-induced apoptosis,  we  tested  whether 
CrmA  could  inhibit  this  process.  Survival  of HeLa  cells 
cultured  for  16  h  under  hypoxic  conditions  was  10.1%, 
compared with 69.0% survival of HeLa cells that stably ex- 
press CrmA  (HeLa/CrmA;  Fig.  1  a).  Thus,  CrmA-inhib- 
itable members of the ICE family play an important role in 
hypoxia-induced  apoptosis.  To  address  whether  endoge- 
nously  produced  mature  IL-1~3  plays  a  role  in  hypoxia- 
induced  cell  death,  we  used  several  methods  to  prevent 
IL-1  from binding to its receptor. We used the IL-1Ra  (a 
naturally occurring cytokine that binds to the  IL-1  recep- 
tor,  blocking IL-l-mediated signal transduction)  (26,  27), 
an anti-IL-1 polyclonal neutralizing antibody, and an anti- 
IL-1 type 1 receptor neutralizing mAb (the type 1 receptor 
mediates  IL-1  signal transduction).  Each  of these  reagents 
inhibited  hypoxia-induced cell death,  suggesting that  hy- 
poxia  activates  an  ICE-like,  CrmA-inhibitable  pathway, 
and that endogenously produced mature IL-113 plays a role 
in hypoxia-induced cell death by binding to the IL-1 type 
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Figure  t.  Hypoxia-induced apoptosis is inhibited by CrmA,  IL-1P,  a, 
anti-IL-1  Ab,  and anti-IL-1  type-I  receptor  antibody.  (A)  HeLa, and 
HeLa/CrmA cells incubated for 16 h under hypoxic conditions with IL- 
1R.a (40 ng/ml),  IL-I antibody (10 ~g/ml),  and IL-1 type 1 receptor an- 
tibody (10 p.g/ml). Results are expressed as the average of four indepen- 
dent experiments. Error bars indicate SEM. (B) IL-11ka  blocks t2Sl-lL-l[3 
receptor binding in HeLa cells. 
1 receptor (Fig.  1 a). We evaluated and confirmed that IL- 
1R.a indeed blocks 12sI-IL-1-~ binding  (Fig.  1 b) (26, 27). 
Endogenous  IL- l fl Mediates  Trophic Factor Deprivation-induced 
Sensory Neuron Apoptosis.  We  next  investigated  in  a  pri- 
mary  culture  system  whether  endogenous  IL-I~  plays  a 
role in apoptosis.  DRG  neurons  undergo  apoptosis in cul- 
ture  upon  NGF  withdrawal  (28).  We  have  previously 
shown  that  chicken  DI:(G  neuronal  death  induced  by 
trophic factor deprivation is inhibited by CrmA, suggesting 
involvement  of the  ICE  family  (10).  We  tested  whether 
endogenously  produced  mature  IL-113, which  is produced 
by  neurons  in  culture  (29),  plays  a  role  in  trophic  factor 
withdrawal-mediated  DRG  neuronal  apoptosis.  Addition 
Figure 2.  IL-1Ra extends neuronal survival after trophic factor depri- 
vation. Postnatal day 1 mouse DRG neurons were isolated, dissociated, 
and allowed to attach overnight. Medium was changed in the morning 
(time 0) and at 24 h. Neurons were scored 24 and 48 h after the initial 
medium  change. TF, trophic  factors (NGF and FCS). Results are ex- 
pressed as the average of three independent experiments. Error bars indi- 
cate SEM. TF(+) ~lled bars), TF(+)/IL--1Ra (striped  bars). TF(-) (empty 
bars), TF(-)/IL-R.a (shaded  bars). 
of IL-1Ra  (100  ng/ml)  to newborn  mouse DRG  neurons 
inhibited  trophic  factor  withdrawal-induced  apoptosis  by 
69.2 and 37.8% over 24 and 48 h, respectively (Fig.  2). In- 
hibition  of neuronal  apoptosis by IL-1Ra was dose depen- 
dent (43.5% in 24 h  at a concentration  of 40 ng/ml).  These 
results  suggest  that  endogenously  produced  mature  IL-lJ3 
plays a role in DI<G neuronal  apoptosis after trophic factor 
withdrawal. 
Secreted IL- l fl Mediates  TNF-ee-induced  Apoptosis  of HeLa 
and L929  Cells.  TNF-o~  induces  apoptosis  via  a  CrmA- 
inhibitable  pathway  (7,  14).  In addition,  we have  demon- 
strated  that  mature  IL-113  is  secreted  by  TNF-e~-treated 
cells undergoing  apoptosis,  suggesting  ICE  activation  dur- 
ing this process (7). We tested whether secreted mature IL- 
1[~ plays a role in TNF-0~-induced  apoptosis of L929  cells. 
IL-1Ra  protected  L929  cells  from TNF-ix-induced  death 
by  up  to  64.9%,  suggesting  that  secretion  and  receptor 
binding  of mature  IL-l[3  plays  a  role  in  TNF-oe-induced 
cell death  (Fig.  3  a).  In addition,  HU-treated,  G~/S phase-- 
arrested  HeLa  cells  are  induced  to  undergo  apoptosis  by 
TNF-0t  (22).  Under  these  conditions,  IL-1Ra  also  inhib- 
ited  HeLa  cell  death  by  56.0%  (Fig.  3  b).  HeLa  cells  in- 
duced to die by TNF-o~ and cyclohexarnide were also pro- 
tected by IL-1Ra,  as well as by three  different neutralizing 
IL-1  antibodies  (data  not  shown).  HeLa/CrmA  cells were 
protected  from TNF-ix-induced  apoptosis by 59.5%,  sug- 
gesting  that  an  ICE-like  activity  is  involved  in  the  cell 
death signaling pathway mediated by this cytokine (Fig.  3  b). 
Mature  IL-I~ alone  does  not  induce  apoptosis  of most 
healthy  proliferating  cells  (including  HeLa  and  L929).  To 
examine  if IL-113 would  induce  cell  death  in  G1/S phase- 
arrested  cells,  we  exposed  HU-treated  HeLa  cells  to  this 
719  Friedlander  et al. Figure  3.  Apoptosis  induced 
by TNF-tx and mature IL-113 is 
mediated by  an  IL-1Ra  inhib- 
itable  pathway.  Percent  cell 
death  in  (a)  L929  cells  treated 
with TNF-ci alone (triangle) and 
TNF-~x plus IL-1Ra (40 ng/ml; 
circle). HU-arrested,  TNF-r  (b), 
or IL-113 (c) -treated HeLa (trian- 
gle),  HeLa/CrmA  (square), and 
HeLa cells treated with  IL-1Ra 
(circle). Results  are  expressed  as 
the average of three independent 
experiments.  Error bars indicate 
SEM. Phase-contrast  and fluores- 
cent  photomicrographs  of  HU- 
arrested  HeLa  cells  (d), treated 
with  TNF-~x  (e), or  IL-113 (f), 
and  stained  with  Hoechst  dye 
(g--i, respectively),  showing con- 
densed and fragmented  nuclei. 
cytokine.  Indeed,  G1/S  phase-arrested  HeLa  cells  treated 
with  exogenous  IL-113  died  in  a  dose-dependent  fashion 
(83.7%  at  100  ng/ml),  which  was  inhibited by the  IL-1Ra 
(Fig. 3  c).  HU-arrested,  mature  IL-113, and TNF-0~-treated 
cells  underwent  typical  apoptotic  changes  of  cellular 
shrinkage,  nuclear condensation,  and fragmentation  (Fig. 3, 
d-  0.  It is interesting  that  HeLa/CrmA  cells were  not  pro- 
tected  against  mature  IL-113  as  they  were  against  TNF-ci 
killing, suggesting that mature  IL-1t3 induces  the apoptotic 
cascade distal to  ICE,  and that in HU  treated cells, this cy- 
tokine causes cell death through  an ICE-independent  path- 
way (Fig. 3  c).  This indicates that CrmA  is indeed blocking 
an  ICE-like function,  and that production  and secretion  of 
mature  IL-113  is  a  downstream  effector  of the  apoptotic 
TNF-o~/ICE  cascade.  HeLa  cells, however,  are required  to 
be primed  (in this case with  HU  arrest)  to establish the ap- 
propriate intracellular milieu to be sensitized to mature  IL- 
113-induced  apoptosis.  HU  treatment  likely mimics  intra- 
cellular signals that are part of the apoptotic cascade. 
IL-l~8  Potentiates  Apoptosis  of  COS  Cells  Induced  by 
ICE.  Next,  we  asked  directly  whether  pro-IL-113  pro- 
cessing  is  required  for  ICE-mediated  apoptosis.  For  this 
Figure 4.  ICE requires pro-lL-118 cleavage and mature IL-1!8 extracellular receptor binding for the induction ofapoptosis in COS cells. Percent cell 
death (a) and X-gal staining of COS cells 36 h after transfection  with Ice-lacZ (b), Ice-lacZ and pro-IL- 1~8 (c), and lce-lacZ treated with mature IL-113 (d). 
Results are expressed as the average of three independent experiments.  Error bars indicate SEM. 
720  Functional Role of IL-113 in ICE-mediated Apoptosis Figure 5.  lrmmunofluorescence  of COS cells transiently transfected with pro-IL-113. (a and b), Ice (c and d), or pro-IL-l[3 plus Ice (e--g). COS cells trans- 
fected with pro-IL-113 and immunostained with an anti-human  polyclonal IL-1 antibody and a secondary RITC-coupled antibody demonstrate nuclear 
and cytoplasmic  morphologic appearance typical of healthy ceils. Cells transfected with Ice and immunostained with an anti-human  ICE mAb and a sec- 
ondary FITC-conjugated antibody display normal cytoplasmic morphology, yet contain condensed nuclei, suggesting the initiation of apoptosis, which 
cannot be completed in the absence of 1L-113. Coexpression of Ice plus pro-IL-I[3 induces typical apoptotic features (condensed nucleus and round mor- 
phology). 
purpose,  we  used  COS  cells.  These  cells  are  unusual  be- 
cause they are resistant to cell death induced by Ice overex- 
pression  (30).  Transfection  of Ice into  Ikat-1  cells  induces 
94.2%  apoptosis  within  24  h  (30).  In  contrast,  COS  cells 
transiently  expressing  Ice-lacZ  or pro-IL-1~  genes  for 36  h 
died 9  and 6.3%, respectively. However,  51% of COS cells 
coexpressing  Ice-lacZ and pro-IL-I~  died,  and  treatment  of 
these double-transfected  cells with IL-1Ra inhibited  apop- 
tosis. In addition, treatment of Ice-lacZ transfected cells with 
extraceUular  mature  IL-I[~  efficiendy  induced  cell  death 
(Fig. 4). Exogenous mature IL-113 did not induce apoptosis 
in COS  cells,  indicating  that ICE processes additional  sub- 
strates required  for cell  death,  and  that in  COS  cells,  after 
ICE  activation,  IL-113  signal  transduction  is  required  for 
the  induction  of  apoptosis.  Dual  immunofluorescence 
staining  (with  anti-ICE  and  anti-IL-1  antibodies)  of COS 
cells  cotransfected  with  Ice  and  pro-IL-l~  indicated  that 
only cells expressing both  ICE and pro-IL-l~, but  not  ei- 
ther protein  alone,  undergo  apoptosis  (Fig.  5). We  consis- 
tently  noticed  that  the  nuclei  of cells  transfected  with  Ice 
were smaller than that of control cells (Fig.  5 c). These cells 
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were  alive,  as  demonstrated  by their  flat morphology  and 
adherence  to the  plate  (Fig.  5  d),  suggesting  that ICE ini- 
tiates  the  apoptotic  process,  but  requires  additional  factors 
(i.e.,  mature  IL-113) for the complete  execution  of the cell 
death pathway. 
Preincubation of Exogenous  IL-1~  Protects Hypoxia-mediated 
Cell Death by Downregutating the IL-1  Receptor.  Conflict- 
ing evidence exists regarding the role oflL-11~ in apoptosis. 
In some systems, IL-113 induces  cell death, whereas in oth- 
ers,  it  inhibits  cell  death  (17-21).  IL-1I~ inhibition  of cell 
death requires its addition before the apoptotic stimulus,  as 
demonstrated  both  with  TNF-0t  killing  of L929  cells  and 
with  excitatory  amino  acid-mediated  neuronal  death  (20, 
21). We determined if exogenous mature IL-1 [3 preincuba- 
tion  inhibits  cell  death  in  a  system where  ICE  activation 
and mature IL-I~ receptor binding are important for apop- 
toffs.  HeLa  cells  preincubated  with  exogenous  IL-113  are 
markedly protected from hypoxia-induced  cell death  (10.1 
vs.  58.7%  survival;  Fig.  6  a).  To  explain  the  inhibition  of 
apoptosis by IL-113, we investigated whether preincubation 
with  exogenous  IL-113  in  our  system  before  exposure  to apoptotic stimuli downregulates the IL-1 receptor (34). In- 
deed, receptor-binding assays demonstrate that exogenous 
IL-113 significantly downregulates the IL-1 receptor (Fig. 6 
b).  Downregulation of the  IL-1  receptor in part  explains 
the protective role of exogenous IL-113, when added be- 
fore the induction ofapoptosis. The effect oflL-l[3 recep- 
tor-binding on apoptosis is dependent on whether ICE is 
active  (enhancing  cell  death)  or  inactive  (inhibiting  cell 
death, in part by downregulating the IL-1 receptor). 
Discussion 
The mammalian ICE/Ced-3 family now includes at least 
six members:  ICE,  ICH-1/NEDD2,  CPP32/Yama/Apo- 
pain,  TX/ICErellI/ICH-2,  ICErelIII, and MCH2  (4,  30, 
32-39). Since this is a family of proteases whose active site 
cysteine  residue  is  essential  for  ICE-mediated  apoptosis, 
their proteolytic activity must be critical in mediating cell 
death (5). How might proteolytic cleavage by the ICE fam- 
ily lead to apoptosis? One possibility is that cleavage of a 
large number of proteins destroys the  entire cellular ma- 
chinery. This is unlikely because most proteins appear to 
remain intact when cells undergo apoptosis (40).  The sec- 
ond possibility is that proteolytic cleavage of one critically 
important substrate leads to cell death. This also is unlikely 
because a number of proteins, including pro-IL-l[3, poly- 
ADP  ribose  polymerase  (PARP),  U1-70  kD  ribonuclear 
protein, and nuclear lamin are cleaved during apoptosis (7, 
40-42).  It is not clear (with the exception of pro-IL-l[3), 
whether the  cleavage products  of these  proteins  mediate 
downstream events of cell death pathways or whether they 
are merely the end result ofapoptosis. The third possibility 
is that activation of the ICE family may result in cleavage of 
several  substrates,  some  being  activated  (mediating  cell 
death)  and  others  being destroyed (required for cell sur- 
vival). The results reported in this study lead us to favor the 
last  hypothesis.  Our data indicate that endogenously pro- 
duced mature IL-1 [3 is directly involved in cell death and is 
the first identified substrate of an apoptosis-inducing gene 
whose product plays  a direct role in mediating the apop- 
totic cascade. 
A  number  of signal  transduction  mechanisms  mediate 
the biological effect of IL-113. Several of these second mes- 
sengers  have been implicated in  apoptosis  and,  after ICE 
activation, they most likely mediate cell death after endog- 
enous mature IL-113 receptor binding. IL-113 induces cera- 
mide production in EL4 thymoma cells (43). IL-113 also in- 
duces  apoptosis  in  pancreatic  RIm5F  cells  via a pathway 
that is dependent on its ability to induce nitric oxide pro- 
duction  (18).  Both  ceramide  and  nitric  oxide are  strong 
candidates for direct mediators of apoptosis (18,  44). A re- 
cent report showed that NGF  deprivation of PC12  cells, 
which induces apoptosis, led to a substantial  activation of 
theJNK and p38 MAP kinases  (45). IL-113 has been shown 
to  activate  the  JNK-p38--signaling  pathway,  and  NGF 
withdrawal may induce secretion of IL-113, which then ac- 
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Figure  6.  (/t) Preincubation  with exogenous  mature IL-113 (100 ng/ 
ml) inhibits hypoxia-mediated apoptosis in  HeLa cells. (/3) 12Sl-IL-l[3 
downregulates the IL-li  3 receptor  in HeLa cells. 
In  light  of our previous  and  current  reported  results, 
which point to a definite role of ICE in apoptosis, it is in- 
trigning that ICE knockout mice are developmentally nor- 
mal  (15,  16).  To date, the only resistance to apoptosis re- 
ported in this mouse is in anti-Fas-mediated thymocyte cell 
death (16).  On the surface, this would seem to contradict 
the notion that ICE itself is important in cell death path- 
ways. However, it is not surprising that knocking out only 
a single member of the ever-growing number of ICE/ced-3 
homologues would not produce a striking apoptotic phe- 
notype, considering the redundancy of such an important 
and terminal process as cellular suicide. Of note, mice with 
homozygous deletions of either Ich-1  or Ich-3 genes dis- 
play grossly  normal development (Bergeron, L.,  M.  Mas- 
ayuki, S. Wang, and J. Yuan, unpublished results). 
Cerebral ischemia induced by middle cerebral artery oc- 
clusion has been shown to result in increased expression of 
IL-1 [3 mRNA in the infarct territory (47). Strikingly, treat- 
ment with the IL-1Ra decreased the ischemia-induced in- 
farct size  by 50%  (48).  In  addition,  the brains  of patients 
with Parkinson's disease,  Alzheimer's disease,  and Down's 
syndrome have  elevated levels  of IL-113 (49,  50).  These 
722  Functional  Role of IL-I~ in ICE-mediated Apoptosis findings suggest that mature IL-113 is involved in mediating 
neuronal  cell  death  pathways  after ischemia,  as  well  as  in 
neurodegenerative diseases.  This might be analogous to the 
notion that a cell needs to be "primed," creating the appro- 
priate  intracellular  milieu  (in  neurons  with  trophic  factor 
deprivation,  in HeLa cells with hypoxia or G1/S phase ar- 
rest,  and in L929 cells  with  TNF-00  for mature  IL-113  to 
activate the cell death program.  In vivo, the "primed" cell 
idea may translate  to an ill  cell that is a burden  to the  or- 
ganism,  and  in  an  example  of cellular  altruism,  the  ICE 
pathway is  activated,  leading to the production  of mature 
IL-113 and culminating in cellular suicide.  However, unin- 
jured cells may be protected by the IL-113 that is produced 
by the  dying cells,  at least  in part  by downregulating  the 
IL-1 receptor, hence rescuing salvageable cells. Mature IL-113 
plays  a pivotal  role  in  cellular homeostasis  by modulating 
the  apoptotic  cascade  and  activating the  immune  system, 
processes  that  are  respectively  involved  in  the  execution 
and elimination of unwanted cells. 
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